Filgotinib-treated rheumatoid arthritis patients with high baseline neutrophil-to-lymphocyte ratio show better clinical response rates and patient-reported outcomes
Main Authors: | , , , , , |
---|---|
Format: | Conference item |
Language: | English |
Published: |
BMJ Publishing Group
2021
|
Summary: |
---|